{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:52:59Z","timestamp":1762429979460},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1992,11,1]],"date-time":"1992-11-01T00:00:00Z","timestamp":720576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1992,11,1]],"date-time":"1992-11-01T00:00:00Z","timestamp":720576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1992,11,1]],"date-time":"1992-11-01T00:00:00Z","timestamp":720576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1992,11,1]],"date-time":"1992-11-01T00:00:00Z","timestamp":720576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[1992,11]]},"DOI":"10.1007\/bf01957926","type":"journal-article","created":{"date-parts":[[2005,7,29]],"date-time":"2005-07-29T22:18:46Z","timestamp":1122675526000},"page":"794-798","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Epstein-Barr virus infection and associated diseases in children"],"prefix":"10.1007","volume":"151","author":[{"given":"V.","family":"Schuster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. W.","family":"Kreth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01957926_CR1","first-page":"107","volume":"85","author":"J Andersson","year":"1988","unstructured":"Andersson, J, Ernberg I (1988) Management of Epstein-Barr virus infections. Am J Med 85:107\u2013115","journal-title":"Am J Med"},{"key":"BF01957926_CR2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/infdis\/153.2.283","volume":"153","author":"J Andersson","year":"1986","unstructured":"Andersson J, Britton S, Ernberg I, Andersson U, Henle W, Sk\u00f6ldenberg B, Tisell \u00c5 (1986) Effect of acyclovir on infectious mononucleosis: A double-blind, placebo-controlled study. J Infect Dis 153:283\u2013290","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"BF01957926_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/BF01650106","volume":"15","author":"J Andersson","year":"1987","unstructured":"Andersson J, Sk\u00f6ldenberg B, Henle W, Giesecke J, \u00d6rtqvist A, Julander I, Gustavsson E, Akerlund B, Britton S, Ernberg I (1987) Acyclovir treatment in infectious mononucleosis: A clinical and virological study. Infection 15 [Suppl 1]:14\u201320","journal-title":"Infection"},{"key":"BF01957926_CR4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ijc.2910220304","volume":"22","author":"RJ Biggar","year":"1978","unstructured":"Biggar RJ, Henle W, Fleisher G, B\u00f6cker J, Lennette ET, Henle G (1978) Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer 22:239\u2013243","journal-title":"Int J Cancer"},{"key":"BF01957926_CR5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/0003-4819-108-2-199","volume":"108","author":"S Blanche","year":"1988","unstructured":"Blanche S, Le Deist F, Veber F, Lenoir G, Fischer AM, Brochier J, Boucheix C, Delaage M, Griscelli C, Fischer A (1988) Treatment of severe Epstein-Barr virus induced polyclonal B-lymphocyte proliferation by anti-B-cell monoclonal antibodies. Two cases after HLA-mismatched bone marrow transplantation. Ann Intern Med 108:199\u2013203","journal-title":"Ann Intern Med"},{"key":"BF01957926_CR6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/08880018909034292","volume":"6","author":"S Blanche","year":"1989","unstructured":"Blanche S, Caniglia M, Fischer A, Griscelli C (1989) Epstein-Barr virus-associated hemophagocytic syndrome: Clinical presentation and treatment. Pediatr Hematol Oncol 6:233\u2013235","journal-title":"Pediatr Hematol Oncol"},{"key":"BF01957926_CR7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-4684-6376-7_3","volume-title":"Infectious mononucleosis","author":"PA Chervenick","year":"1989","unstructured":"Chervenick PA (1989) Infectious mononucleosis: the classic clinical syndrome. In: Schlossberg D (Ed) Infectious mononucleosis, 2nd ed, Springer, Berlin Heidelberg New York, pp. 29\u201334","edition":"2nd ed"},{"key":"BF01957926_CR8","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJM199105233242102","volume":"324","author":"A Fischer","year":"1991","unstructured":"Fischer A, Blanche S, Le Bidois J, Bordigoni P, Garnier J, Niaudet P, Morinet F, Le Deist F, Fischer A, Griscelli C, Hirn M (1991) Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 324:1451\u20131456","journal-title":"N Engl J Med"},{"key":"BF01957926_CR9","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0022-3476(79)80138-9","volume":"94","author":"G Fleisher","year":"1979","unstructured":"Fleisher G, Lennette ET, Henle G, Henle W (1979) Incidence of heterophil antibody response in children with infectious mononucleosis. J Pediatr 94:723\u2013728","journal-title":"J Pediatr"},{"key":"BF01957926_CR10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ajh.2830280412","volume":"28","author":"JE Grishaber","year":"1988","unstructured":"Grishaber JE, McClain KL, Mahoney DH, Fernbach DJ (1988) Successful outcome of severe aplastic anemia following Epstein-Barr virus infection. Am J Hematol 28:273\u2013275","journal-title":"Am J Hematol"},{"key":"BF01957926_CR11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM198204153061506","volume":"306","author":"DW Hanto","year":"1982","unstructured":"Hanto DW, Frizzera G, Gajl-Peczlaska KJ, Sakamoto K, Purtilo DT, Balfour HH, Simmons RL, Najarian JS (1982) Epstein-Barr virus induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med 306:913\u2013918","journal-title":"N Engl J Med"},{"key":"BF01957926_CR12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jso.2930300406","volume":"30","author":"DW Hanto","year":"1985","unstructured":"Hanto DW, Najarian JS (1985) Advances in the diagnosis and treatment of EBV-associated lymphoproliferative diseases in immunocompromised hosts. J Surg Oncol 30:215\u2013220","journal-title":"J Surg Oncol"},{"key":"BF01957926_CR13","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1073\/pnas.84.2.570","volume":"84","author":"W Henle","year":"1987","unstructured":"Henle W, Henle G, Andersson J, Ernberg I, Klein G, Horwitz CA, Marklund G, Rymo L, Wellinder C, Straus SE (1987) Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc Natl Acad Sci USA 84:570\u2013574","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01957926_CR14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/infdis\/163.1.53","volume":"163","author":"I Joab","year":"1991","unstructured":"Joab I, Triki H, Saint Martin J de, Perricaudet M, Nicolas JC (1991) Detection of anti-Epstein-Barr virus trans-activator (ZEBRA) antibodies in sera from patients with human immunodeficiency virus. J Infect Dis 163:53\u201356","journal-title":"J Infect Dis"},{"key":"BF01957926_CR15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/infdis\/153.3.601","volume":"153","author":"BZ Katz","year":"1986","unstructured":"Katz BZ, Andiman WA, Eastman R, Martin K, Miller G (1986) Infection with two genotypes of Epstein-Barr virus in an infant with AIDS and lymphoma of the central nervous system. J Infect Dis 153:601\u2013604","journal-title":"J Infect Dis"},{"key":"BF01957926_CR16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/infdis\/160.4.589","volume":"160","author":"BZ Katz","year":"1989","unstructured":"Katz BZ, Raab-Traub N, Miller G (1989) Latent and replicative forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. J Infect Dis 160:589\u2013598","journal-title":"J Infect Dis"},{"key":"BF01957926_CR17","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1128\/AAC.32.7.1068","volume":"32","author":"JC Lin","year":"1988","unstructured":"Lin JC, Machida H (1988) Comparison of two bromovinyl nucleoside analogs, 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl) uracil and E-5-(2-bromovinyl)-2\u2032-deosyuridine, with acyclovir in inhibition of Epstein-Barr virus replication. Antimicrob Agents Chemother 32:1068\u20131072","journal-title":"Antimicrob Agents Chemother"},{"key":"BF01957926_CR18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1126\/science.6306771","volume":"223","author":"JC Lin","year":"1983","unstructured":"Lin JC, Smith MC, Cheng Y-C (1983) Epstein-Barr virus: Inhibition of replication by three new drugs. Science 223:578\u2013579","journal-title":"Science"},{"key":"BF01957926_CR19","unstructured":"Lin JC, Raab-Traub N, Pagano J (1990) Disruption of Epstein-Barr virus episomal DNA maintenance by a specific oligodeoxyribonucleotide. 4th Int Symp on EBV and associate malignant diseases, Hualien, Taiwan, Sept 23\u201328, abstract F3.2, p 19"},{"key":"BF01957926_CR20","first-page":"563","volume-title":"Virology, Chapter 27","author":"G Miller","year":"1985","unstructured":"Miller G (1985) Epstein-Barr virus, in. Virology, Chapter 27 (ed. by Fields BN et al), Raven Press, New York, pp 563\u2013589"},{"key":"BF01957926_CR21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jmv.1890290114","volume":"29","author":"AJ Morgan","year":"1989","unstructured":"Morgan AJ, Allison AC, Finerty S, Scullion FT, Byars NE, Epstein MA (1989) Validation of a first-generation Epstein-Barr virus vaccine preparation suitable for human use. J Med Virol 29:74\u201378","journal-title":"J Med Virol"},{"key":"BF01957926_CR22","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1128\/jvi.64.3.1348-1352.1990","volume":"64","author":"GR Nemerow","year":"1990","unstructured":"Nemerow GR, Mullen JJ (1990) Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection. J Virol 64:1348\u20131352","journal-title":"J Virol"},{"key":"BF01957926_CR23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1128\/CMR.1.3.300","volume":"1","author":"M Okano","year":"1988","unstructured":"Okano M, Thiele GM, Davis JR, Grierson HL, Purtilo DT (1988) Epstein-Barr virus and human diseases: Recent advances in diagnosis. Clin Microbiol Rev 1:300\u2013312","journal-title":"Clin Microbiol Rev"},{"key":"BF01957926_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/BF00917127","volume":"9","author":"M Okano","year":"1989","unstructured":"Okano M, Thiele GM, Kobayashi RH, Davis JR, Synovec MS, Grierson HL, Jaffe HS, Purtilo DT (1989) Interferon-gamma in a family with X-linked lymphoproliferative syndrome with acute Epstein-Barr virus infection. J Clin Immunol 9:48\u201354","journal-title":"J Clin Immunol"},{"key":"BF01957926_CR25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00043426-199022000-00008","volume":"12","author":"M Okano","year":"1990","unstructured":"Okano M, Thiele G, Purtilo DT (1990) Severe chronic active Epstein-Barr virus infection syndrome and adenovirus type-2 infection. Am J Pediatr Hematol Oncol 12:168\u2013173","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"BF01957926_CR26","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/0090-1229(90)90054-T","volume":"54","author":"M Okano","year":"1990","unstructured":"Okano M, Pirruccello SC, Grierson HL, Johnson DR, Thiele GM, Purtilo DT (1990) Immunovirological studies of fatal infectious mononucleosis in a patient with X-linked lymphoproliferative syndrome treated with intravenous immunoglobulin and interferon alpha. Clin Immunol Immunopathol 54:410\u2013418","journal-title":"Clin Immunol Immunopathol"},{"key":"BF01957926_CR27","doi-asserted-by":"crossref","unstructured":"Pagano JS, Lin JC (1989) Challenges in the treatment of EBV-associated diseases: New approaches. In: Ablashi DV, Faggioni A, Kr\u00fcger G, Pagano J, Pearson G (eds) Epstein-Barr virus and human disease 1988, Humana Press, pp 315\u2013327","DOI":"10.1007\/978-1-4612-4508-7_48"},{"key":"BF01957926_CR28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-4684-6376-7_8","volume-title":"Infectious mononucleosis","author":"G Pearson","year":"1989","unstructured":"Pearson G (1989) Infectious mononucleosis: the humoral response. In: Schlossberg D (ed) Infectious mononucleosis, 2nd edition, Springer, Berlin Heidelberg New York, pp 89\u201399","edition":"2nd edition"},{"key":"BF01957926_CR29","first-page":"4226","volume":"41","author":"DT Purtilo","year":"1981","unstructured":"Purtilo DT, Sakamoto K, Saemundsen AK, Sullivan JL, Synnerholm A-C, Anvret M, Pritchard J, Sloper C, Sieff C, Pincott J, Pachman L, Rich K, Cruci F, Cornet J, Collins R, Barnes N, Knight J, Sandstedt B, Klein G (1981) Documentation of Epstein-Barr virsus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological Studies. Cancer Res 41:4226\u20134235","journal-title":"Cancer Res"},{"key":"BF01957926_CR30","first-page":"113","volume":"27","author":"DT Purtilo","year":"1985","unstructured":"Purtilo DT, Tatsumi E, Manolov G, Manolova Y, Harada S, Lipscomb H, Krueger G (1985) Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients (1985) Int Rev Exp Pathol 27:113\u2013183","journal-title":"Int Rev Exp Pathol"},{"key":"BF01957926_CR31","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1001\/jama.259.3.384","volume":"15","author":"L Resnick","year":"1988","unstructured":"Resnick L, Herbst JS, Ablashi DV, Atherton S, Frank B, Rosen L, Horwitz S (1988) Regression of oral \u2018hairy\u2019 leukoplakia after orally administered acyclovir therapy. JAMA 15:384\u2013388","journal-title":"JAMA"},{"key":"BF01957926_CR32","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/infdis\/149.5.763","volume":"149","author":"T Sairenji","year":"1984","unstructured":"Sairenji T, Sullivan JL, Humphreys RE (1984) Complement-dependent, Epstein-Barr virus-neutralizing antibody appearing early in the sera of patients with infectious mononucleosis. J Infect Dis 149:763\u2013768","journal-title":"J Infect Dis"},{"key":"BF01957926_CR33","doi-asserted-by":"crossref","first-page":"636","DOI":"10.7326\/0003-4819-104-5-636","volume":"104","author":"R Schooley","year":"1986","unstructured":"Schooley R, Carey R, Miller G, Henle W, Eastman R, Mark E, Kenyon K, Wheeler E, Rubin R (1986) Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Ann Intern Med 104:636\u2013643","journal-title":"Ann Intern Med"},{"key":"BF01957926_CR34","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/jmv.1890190310","volume":"19","author":"V Schuster","year":"1986","unstructured":"Schuster V, Matz B, Wiegand H, Polack A, Corsten B, Neumann-Haefelin D (1986) Nucleic acid hybridization for detection of herpes viruses in clinical specimens. J Med Virol 19:672\u2013676","journal-title":"J Med Virol"},{"key":"BF01957926_CR35","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/infdis\/162.3.642","volume":"162","author":"TB Sculley","year":"1990","unstructured":"Sculley TB, Apolloni A, Hurren L, Moss DJ, Cooper DA (1990) Coinfection with A- and B-type Epstein-Barr virus in human immunodeficieny virus-positive subjects. J Infect Dis 162:643\u2013648","journal-title":"J Infect Dis"},{"key":"BF01957926_CR36","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ijc.2910400311","volume":"40","author":"JM Seigneurin","year":"1987","unstructured":"Seigneurin JM, Lavoue MF, Genoulaz O, Bornkamm GW, Lenoir GM (1987) Antibody response against the Epstein-Barr virus-coded nuclear antigen 2 (EBNA 2) in different groups of individuals. Int J Cancer 40:340\u2013353","journal-title":"Int J Cancer"},{"key":"BF01957926_CR37","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJM198805193182013","volume":"318","author":"RS Shapiro","year":"1988","unstructured":"Shapiro RS, Chauvenet A, McGuire W, Pearson A, Craft AW, McGlave P, Filipovich A (1988) Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin. N Engl J Med 318:1334","journal-title":"N Engl J Med"},{"key":"BF01957926_CR38","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood.V77.7.1527.1527","volume":"77","author":"D Shibata","year":"1991","unstructured":"Shibata D, Weiss LM, Nathwani BN, Brynes RK, Levine AM (1991) Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of Non-Hodgkin's lymphoma. Blood 77:1527\u20131533","journal-title":"Blood"},{"key":"BF01957926_CR39","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0140-6736(89)90829-5","volume":"II","author":"JW Sixbey","year":"1989","unstructured":"Sixbey JW, Shirley P, Chesney PJ, Buntin DM, Resnick L (1989) Detection of a second widespread strain of Epstein-Barr virus. Lancet II:761\u2013765","journal-title":"Lancet"},{"key":"BF01957926_CR40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0140-6736(84)90994-2","volume":"I","author":"TE Starzl","year":"1984","unstructured":"Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, Rosenthal JT, Halaka TR, Shaw BW Jr, Hardesty RL, Atchison RW, Jaffe R, Bahnson HT (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet I:583\u2013587","journal-title":"Lancet"},{"key":"BF01957926_CR41","first-page":"365","volume-title":"Advances in Pediatrics Vol 30","author":"JL Sullivan","year":"1983","unstructured":"Sullivan JL (1983) Epstein-Barr virus and the X-linked lymphoproliferative syndrome. In: Barness LA (ed). Advances in Pediatrics Vol 30, Year Book Medical Publishers, Chicago, pp 365\u2013399"},{"key":"BF01957926_CR42","first-page":"325","volume":"1","author":"JS Sullivan","year":"1989","unstructured":"Sullivan JS, Woda BA (1989) X-linked lymphoproliferative syndrome. Immunodefic Rev 1:325\u2013347","journal-title":"Immunodefic Rev"},{"key":"BF01957926_CR43","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0002-9343(82)90102-4","volume":"73","author":"JL Sullivan","year":"1982","unstructured":"Sullivan JL, Byron KS, Brewster FE, Sakamoto K, Shaw JE, Pagano JS (1982) Treatment of life-threatening Epstein-Barr virus infections with acyclovir. Am J Med 73:262\u2013266","journal-title":"Am J Med"},{"key":"BF01957926_CR44","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM198411013111806","volume":"311","author":"JL Sullivan","year":"1984","unstructured":"Sullivan JL, Medveczky P, Forman SJ, Baker SM, Monroe JE, Mulder C (1984) Epstein-Barr virus induced lymphoproliferation. Implications for antiviral chemotherapy. N Engl J Med 311:1163\u20131167","journal-title":"N Engl J Med"},{"key":"BF01957926_CR45","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1542\/peds.75.6.1011","volume":"75","author":"CV Sumaya","year":"1985","unstructured":"Sumaya CV, Ench Y (1985) Epstein-Barr virus infectious mononucleosis in children. II. Heterophil antibody and viral-specific responses. Pediatrics 75:1011\u20131019","journal-title":"Pediatrics"},{"key":"BF01957926_CR46","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/00007890-199005000-00022","volume":"49","author":"JA Thomas","year":"1990","unstructured":"Thomas JA, Hotchin NA, Allday MJ, Amlot P, Rose M, Yacoub M, Crawford DH (1990) Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation 49:944\u2013953","journal-title":"Transplantation"},{"key":"BF01957926_CR47","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/eji.1830181106","volume":"18","author":"D Ulaeto","year":"1988","unstructured":"Ulaeto D, Wallace L, Morgan A, Morein B, Rickinson AB (1988) In vitro T-cell responses to a candidate Epstein-Barr virus vaccine: human CD4+T-cell clones specific for the major envelope glycoprotein gp340. Eur J Immunol 18:1689\u20131697","journal-title":"Eur J Immunol"},{"key":"BF01957926_CR48","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/infdis\/164.4.788","volume":"164","author":"C Van der Horst","year":"1991","unstructured":"Van der Horst C, Joncas J, Ahronheim G, Gustafson N, Stein G, Gurwith M, Fleisher G, Sullivan J, Sixbey J, Roland S, Fryer J, Champney K, Schooley R, Sumaya C, Pagano JS (1991) Lack of effect of peroral acyclovir for the treatment of acute infectious mononucleosis. J Infect Dis 164:788\u2013792","journal-title":"J Infect Dis"},{"key":"BF01957926_CR49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ijc.2910430115","volume":"43","author":"QY Yao","year":"1989","unstructured":"Yao QY, Ogan P, Rowe M, Wood M, Rickinson AB (1989) Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers. Int J Cancer 43:67\u201371","journal-title":"Int J Cancer"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01957926.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF01957926\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01957926","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01957926.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:09:00Z","timestamp":1659053340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF01957926"}},"subtitle":["II. Diagnostic and therapeutic strategies"],"short-title":[],"issued":{"date-parts":[[1992,11]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1992,11]]}},"alternative-id":["BF01957926"],"URL":"https:\/\/doi.org\/10.1007\/bf01957926","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,11]]},"assertion":[{"value":"17 May 1990","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 1991","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}